Efficacy and Safety of Lactobacillus reuteri CCFM1040 in Allergic Rhinitis and Asthma: A Randomized, Placebo-Controlled Trial

The coexistence of allergic rhinitis (AR) and asthma reinforces the concept of “one airway, one disease,” which has prompted the exploration for a single intervention to treat both diseases. Lactobacillus reuteri CCFM1040 (CCFM1040) was found to be an inhibitor of the common pathogenesis of AR and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lingzhi, Fang, Zhifeng, Lee, Yuan-kun, Zhao, Jianxin, Zhang, Hao, Peng, Huaiming, Zhang, Yulong, Lu, Wenwei, Chen, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Nutrition
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022948/
https://www.ncbi.nlm.nih.gov/pubmed/35464005
http://dx.doi.org/10.3389/fnut.2022.862934

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9022948/
https://www.ncbi.nlm.nih.gov/pubmed/35464005
http://dx.doi.org/10.3389/fnut.2022.862934

Ejemplares similares